Peer Reviewed
Sheet Barrier and Intubating Stylet

Coronavirus disease 2019 (COVID-19), a respiratory syndrome caused by SARS-CoV-2, can be transmitted through respiratory droplets and aerosols of droplet nuclei. Aerosol-generating medical procedures (AGMP) are needed to take care of critically ill patients but place health care providers at risk of infection. With limited supplies of personal protective equipment (PPE), barrier systems were developed to help protect health care providers during tracheal intubation. The video intubating stylet shows promise to become the preferred intubation device in conjunction with plastic sheet barriers during the COVID-19 pandemic.

COVID-19 endotracheal intubation tracheal intubation video intubating stylet plastic sheet barrier

Since the first case of viral pneumonia was reported from Wuhan, China in late December of 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen for the Coronavirus disease 2019 (COVID-19) pandemic, has run rampant across the world [1]. As of 30 September 2021, there have been 232,636,622 confirmed cases and 4,762,089 COVID deaths [2]. As cases grew at an alarmingly exponential rate, it was quickly identified that COVID-19 could be transmitted through respiratory droplets and even through the aerosolization of droplet nuclei [3][4]. Because of the pathology and progression of the disease towards respiratory failure, aerosol-generating medical procedures (AGMP) such as laryngoscopy, endotracheal intubation and extubation, tracheostomy, bronchoscopy and bronchoalveolar lavage, positive pressure ventilation, cardiopulmonary resuscitation with bag-valve-mask, suctioning, and nasopharyngeal aspiration and washing would be necessary to take care of patients with COVID-19 infection [5]. Healthcare providers in the fields of anesthesiology, critical care medicine, emergency medicine, and otolaryngology, because of their roles in performing AGMPs for these patients, found themselves at risk of infection.

References

  1. Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497–506.
  2. Data: WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int (accessed on 30 September 2021).
  3. Yuki, K.; Fujiogi, M.; Koutsogiannaki, S. COVID-19 pathophysiology: A review. Clin. Immunol. 2020, 215, 108427.
  4. Hu, B.; Guo, H.; Zhou, P.; Shi, Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021, 19, 141–154.
  5. Wax, R.S.; Christian, M.D. Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients. Can. J. Anaesth. 2020, 67, 568–576.
More
Related Content
In the context of digitalizing healthcare systems, digital health sources (DHSs) aim to enhance the efficiency, accessibility, and quality of healthcare services by leveraging technology. Multiple types of DHSs are increasingly established in healthcare, providing direct and wide communication between pediatric patients, parents, and healthcare professionals. Therefore, they are considered promising key tools to improve pediatric disease monitoring and management. At the same time, DHSs have been associated with several issues and risks, such as those related to data sharing, privacy, and the cultural readiness of the users. Yet, discussions in the literature have mostly focused on technical considerations and a user-friendly design. In contrast, the contribution of DHSs to treatment engagement in pediatric populations and data sharing has only partially been discussed. On this basis, we provide an overview of the available digital health technologies and their application in the pediatric population with chronic suppurative lung diseases; we describe the effectiveness in health-related outcomes, discuss possible challenges, and propose some recommendations that may overcome barriers in their everyday use.
Keywords: children; chronic suppurative lung disease; digital health sources; pediatric pulmonary disease
The following concerns and measures of neurotrauma are discussed here: It expands more on the protection role that the skull encompasses regarding the encephalon together with a detailed explanation of the effects of head injuries and their implications, which may include coma or death as a result of fractures or dysfunctions. The text gives descriptions of the incidence, especially in car-related accidents, and details about TBI such as the symptoms and the issues likely to occur as a result of the injury. The paper also draws attention to certain dangerous behaviors; such as; non-utilization of seat belts, driving when drunk, no helmet usage, and inadequate supervision to eliminate traumatic brain injury. Among the changes in management of the TBIs whether surgical or through medication, the text lastly highlights the fact that more emphasis has been placed on preventing this condition than on finding a cure for it.
Keywords: Concussions; Contusions; CT scans; Encephalon; Hematoma; MRI scans; Seizures; Stroke
Pneumovax 23 Image
Pneumovax 23 by MSD, box and one-dose vial, as sold in South Africa.
Keywords: bacteria; Streptococcus pneumoniae
Incubation of larynx in diptheria.
Keywords: bacteria; larynx
Rotarix Image
Rotarix, brand name for an oral vaccine against rotavirus infection.
Keywords: virus; rotavirus
Information
Subjects: Respiratory System
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 1.6K
Online Date: 25 Oct 2021
Video Production Service